about
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions...
Read More
3.46
0.17
(5.17%)
39,309
XNAS Volume
XNAS 27 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Synaptogenix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..